These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 26966671)
61. Correlation between Preoperative Serum Albumin-Globulin Ratio and Prognosis of Patients Undergoing Low Rectal Cancer Surgery. Rong G; Liu S; Xi C; Wang C; Deng J; Qin T Clin Lab; 2022 Jan; 68(1):. PubMed ID: 35023685 [TBL] [Abstract][Full Text] [Related]
62. Peripheral blood nutrient indices as biomarkers for anti‑PD‑1 therapy efficacy and prognosis in patients with advanced gastric cancer. Wang X; Liu X; Dai H; Jia J Oncol Lett; 2023 Sep; 26(3):397. PubMed ID: 37600335 [TBL] [Abstract][Full Text] [Related]
63. Predicting the Prognosis of Gastric Cancer by Albumin/Globulin Ratio and the Prognostic Nutritional Index. Zhang Y; Zhu JY; Zhou LN; Tang M; Chen MB; Tao M Nutr Cancer; 2020; 72(4):635-644. PubMed ID: 31423840 [No Abstract] [Full Text] [Related]
64. Prognostic Nutritional Index, Another Prognostic Factor for Extranodal Natural Killer/T Cell Lymphoma, Nasal Type. Yao N; Hou Q; Zhang S; Xiao H; Liang Y; Xu X; Guo R; Li H; Lan S; Si H; Cao J Front Oncol; 2020; 10():877. PubMed ID: 32637354 [No Abstract] [Full Text] [Related]
65. Preoperative albumin/globulin ratio is a potential prognosis predicting biomarker in patients with resectable gastric cancer. Xue F; Lin F; Yin M; Feng N; Zhang X; Cui YG; Yi YP; Kong XY; Chen X; Liu WZ Turk J Gastroenterol; 2017 Nov; 28(6):439-445. PubMed ID: 29086711 [TBL] [Abstract][Full Text] [Related]
66. Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma. Yhim HY; Kim JS; Mun YC; Moon JH; Chae YS; Park Y; Jo JC; Kim SJ; Yoon DH; Cheong JW; Kwak JY; Lee JJ; Kim WS; Suh C; Yang DH; Biol Blood Marrow Transplant; 2015 Sep; 21(9):1597-604. PubMed ID: 25963920 [TBL] [Abstract][Full Text] [Related]
67. Prognostic Significance of Albumin-Globulin Ratio in Urachal Carcinoma. Chen H; Wu M; Chen M Urol Int; 2024 Sep; ():1-10. PubMed ID: 39342932 [TBL] [Abstract][Full Text] [Related]
68. Preoperative albumin to globulin ratio predicts survival in clear cell renal cell carcinoma patients. Chen Z; Shao Y; Yao H; Zhuang Q; Wang K; Xing Z; Xu X; He X; Xu R Oncotarget; 2017 Jul; 8(29):48291-48302. PubMed ID: 28187463 [TBL] [Abstract][Full Text] [Related]
69. Clinical Impact of Preoperative Albumin-Globulin Ratio in Patients with Rectal Cancer Treated with Preoperative Chemoradiotherapy. Toiyama Y; Oki S; Okugawa Y; Ide S; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Ohi M; Inoue Y; Araki T; Kusunoki M Oncology; 2018; 95(5):270-280. PubMed ID: 29996133 [TBL] [Abstract][Full Text] [Related]
70. A novel prognostic model based on pretreatment serum albumin and ECOG PS for primary CNS lymphoma: an international, multi-center study. Wei L; Gao Y; Prochazka KT; Liu R; Wang L; Liu B; He Y; Bertero L; Pellerino A; Cassoni P; Tamagnone L; Deutsch AJ; Zhan H; Lai J; Kim SJ; You H J Neurooncol; 2023 Jun; 163(2):301-311. PubMed ID: 37231231 [TBL] [Abstract][Full Text] [Related]
71. Preoperative albumin-to-globulin ratio and prognostic nutrition index predict prognosis for glioblastoma. Xu WZ; Li F; Xu ZK; Chen X; Sun B; Cao JW; Liu YG Onco Targets Ther; 2017; 10():725-733. PubMed ID: 28223828 [TBL] [Abstract][Full Text] [Related]
72. The association between albumin-globulin ratio (AGR) and survival in patients treated with immune checkpoint inhibitors. Guven DC; Aktepe OH; Aksun MS; Sahin TK; Kavgaci G; Ucgul E; Cakir IY; Yildirim HC; Guner G; Akin S; Kertmen N; Dizdar O; Aksoy S; Erman M; Yalcin S; Kilickap S Cancer Biomark; 2022; 34(2):189-199. PubMed ID: 34958005 [TBL] [Abstract][Full Text] [Related]
73. Evaluation and Validation of the Prognostic Value of Serum Albumin to Globulin Ratio in Patients With Cancer Cachexia: Results From a Large Multicenter Collaboration. Xie HL; Zhang Q; Ruan GT; Ge YZ; Hu CL; Song MM; Song CH; Zhang X; Zhang XW; Li XR; Zhang KP; Liu T; Yang M; Tang M; Xu HX; Shi HP Front Oncol; 2021; 11():707705. PubMed ID: 34568033 [TBL] [Abstract][Full Text] [Related]
74. CD56-Negative Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Study in 443 Patients Treated by Chemotherapy With or Without Asparaginase. Yang J; Li P; Piao Y; Liu X; Wei L; Sang W; Zhang L; Wang L Front Immunol; 2022; 13():829366. PubMed ID: 35371002 [TBL] [Abstract][Full Text] [Related]
75. A New Prognostic Index for Extranodal Natural Killer/T-Cell Lymphoma:Incorporation of Serum β-2 Microglobulin to PINK. Kang S; Cho H; Kim S; Lee K; Kang EH; Park JS; Lee YS; Park CS; Go H; Huh J; Ryu JS; Lee SW; Kim SJ; Kim WS; Yoon SE; Ko YH; Suh C Cancer Res Treat; 2023 Jan; 55(1):314-324. PubMed ID: 35381163 [TBL] [Abstract][Full Text] [Related]
76. The Prognostic Value of Albumin-Globulin Ratio and Eosinophil-Neutrophil Ratio in Patients with Advanced Tumors Undergoing Treatment with PD-1/PD-L1 Inhibitors. Ma Y; Shang K; Wu S; Wang J; Cao B Nutr Cancer; 2022; 74(8):2815-2828. PubMed ID: 35102801 [TBL] [Abstract][Full Text] [Related]
77. Pretreatment albumin globulin ratio has a superior prognostic value in laryngeal squamous cell carcinoma patients: a comparison study. Zhou T; Yu ST; Chen WZ; Xie R; Yu JC J Cancer; 2019; 10(3):594-601. PubMed ID: 30719156 [No Abstract] [Full Text] [Related]
78. Clinical burden of preoperative albumin-globulin ratio in esophageal cancer patients. Oki S; Toiyama Y; Okugawa Y; Shimura T; Okigami M; Yasuda H; Fujikawa H; Okita Y; Yoshiyama S; Hiro J; Kobayashi M; Ohi M; Araki T; Inoue Y; Mohri Y; Kusunoki M Am J Surg; 2017 Nov; 214(5):891-898. PubMed ID: 28460738 [TBL] [Abstract][Full Text] [Related]
79. Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma. Kim WY; Jeon YK; Kim TM; Kim JE; Kim YA; Lee SH; Kim DW; Heo DS; Kim CW Ann Oncol; 2009 Oct; 20(10):1688-96. PubMed ID: 19542249 [TBL] [Abstract][Full Text] [Related]
80. Development of new prognostic model based on pretreatment βLRI and LLRI for stage IE/IIE upper aerodigestive tract ENKTL, nasal type. Dai W; Jia B; Yang J; Zhou S; Liu P; He X; Qin Y; Gui L; Zhang C; Han X; Sun Y; Shi Y Oncotarget; 2017 May; 8(21):34787-34795. PubMed ID: 28410236 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]